Literature DB >> 1698309

Monocyte function in IDDM patients and healthy individuals.

J Mølvig1, F Pociot, L Baek, H Worsaae, L Dall Wogensen, P Christensen, L Staub-Nielsen, T Mandrup-Poulsen, K Manogue, J Nerup.   

Abstract

Interleukin 1 beta (IL-1 beta) and tumour necrosis factor alpha (TNF-alpha) may be pathogenetically important in insulin-dependent diabetes mellitus (IDDM), which is associated with genes of the HLA region. Since a regulatory role of HLA region genes on monokine production may exist, we looked for an association between the monokine and prostaglandin E2 (PGE2) responses of monocytes (Mo) from 20 healthy males (18-50 years) with HLA-DR types relevant for IDDM susceptibility and resistance (DR1,2, DR1,3, DR1,4, DR3,4). Monokine assays were established and evaluated and the secretions of IL-1 beta, TNF-alpha, and PGE2 measured in Mo cultures (2h, 6h, 20h) prepared by endotoxin-free techniques and stimulated by low-dose E. coli lipopolysaccharides (LPS). There were no significant associations between Mo responses and HLA-DR phenotype. Likewise, Mo from DR2 (n = 5) and DR4 (n = 5) homozygous healthy males demonstrated no significant differences in monokine and PGE2 responses of Mo. In the HLA class III region a diallelic TNF-beta gene NcoI polymorphism consisting of alleles of 5.5 kb and 10.5 kb was recently described and associated with susceptibility to autoimmune diseases including IDDM. We report that IL-1 beta and TNF-alpha responses of Mo from TNF-beta 10.5 kb homozygous healthy individuals were significantly higher than for TNF-beta 5.5/10.5 kb heterozygotes. IL-1 beta and TNF-alpha responses of Mo from males (18-35 years) with newly diagnosed (n = 10) and long-standing IDDM (n = 10) and from age- and HLA-DR-matched healthy males (n = 10) were studied. LPS, gamma interferon (IFN), and TNF-alpha-stimulated Mo cultures were investigated. No significant differences were found between Mo responses of IDDM patients and controls. IFN (1000 U/ml) in the presence of LPS significantly potentiated LPS-stimulated Mo TNF-alpha secretion and reduced the levels of IL-1 beta immunoreactivity in Mo lysates. IFN and TNF-alpha did not have any effects on LPS-stimulated Mo secretion of IL-1 beta immunoreactivity. We conclude that Mo IL-1 beta and TNF-alpha production is normal in patients with recent-onset and long-standing IDDM. The interindividual differences in monokine responses may be accounted for by the diallelic human TNF-beta gene polymorphism rather than by HLA class II genes. This observation may be important for understanding the association of certain HLA haplotypes with autoimmune phenomena and disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698309     DOI: 10.1111/j.1365-3083.1990.tb02924.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Relation of a TNF gene polymorphism to severe sepsis in trauma patients.

Authors:  M Majetschak; S Flohé; U Obertacke; J Schröder; K Staubach; D Nast-Kolb; F U Schade; F Stüber
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients.

Authors:  Matthias Majetschak; Udo Obertacke; F Ulrich Schade; Mark Bardenheuer; Gregor Voggenreiter; Brunhilde Bloemeke; Michael Heesen
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM.

Authors:  A el-Nawawy; T Soliman; O el-Azzouni; A A Abbassy; M N Massoud; S Marzouk; F Ibrahim; L Helal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

5.  Tumour necrosis factor-beta polymorphism is unlikely to determine susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Jenkins; M A Penny; C H Mijovic; K H Jacobs; J Fletcher; A H Barnett
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

6.  Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients.

Authors:  K Josefsen; H Nielsen; S Lorentzen; P Damsbo; K Buschard
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas.

Authors:  D E Picarella; A Kratz; C B Li; N H Ruddle; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.